Although orphan drug legislation and genomic science have transformed the therapeutic landscape for rare diseases, the path from scientific discovery to patient access remains complex and uncertain.
Orphan Drugs: From Neglect to Precision Medicine
Although orphan drug legislation and genomic science have transformed the therapeutic landscape for rare diseases, the path from scientific discovery to patient access remains complex and uncertain.
Understanding Inheritance Patterns in Genetic Conditions
A clear guide to genetic inheritance patterns, explaining how conditions are passed through families and why outcomes can vary across generations.
Support For Rare Disease Patients and Families
Rare disease support: NORD, Global Genes, peer groups, financial help, insurance guidance, and online communities to fight isolation.
The Financial Burden of Rare Diseases on Families
Rare diseases create hidden financial strain through delayed diagnosis, costly treatments, income loss, and long-term care burdens.
Telehealth for Rare Diseases: How Remote Care Makes a Difference
Telehealth is transforming rare disease care by improving access to specialists, supporting remote monitoring, and reducing barriers to care.
FDA's New Breakthrough Pathways for Rare Disease Treatments
A clear overview of the FDA’s new 2025 pathways transforming rare disease drug development, including RDEP, guidance updates, and mechanism based approval.
Understanding Rare Diseases: An Overview of Definitions and Prevalence
Discover how rare diseases are defined worldwide, why definitions differ, and what current data reveals about prevalence, diagnosis delays, and the treatment gap.
How Many Rare Diseases Are There? Understanding the Global Numbers
Learn why estimates place rare diseases between 7,000 and 10,000 worldwide, how definitions differ, and how genomics is reshaping our understanding of prevalence.